title: [Pure gonadal dysgenesis XX and XY: observations in fifteen patients].
abstract: BACKGROUND
  Pure gondal dysgenesis is characterized by impuberism with a female phenotype without genital ambiguity. The aim of the study is to describe the diagnostic and therapeutic patterns as well as the clinical features.
  
  
  METHODS
  A retrospective study of 15 patients with pure gonadal dysgenesis (15 patients, 46 XX and two 46 XY). Clinical parameters, familial cases, serum gonadotropin levels, pelvic ultrasonography, endoscopic data, karyotype, analysis of SRY (sex determining Y chromosome) and therapeutic control and clinical course were recorded.
  
  
  RESULTS
  Average age at diagnosis was 21+/-2.83 years. Primary amenorrhea was the most frequent reason for consultation. A familial case was found in five patients. The association of sensorineural deafness was noted in one patient, suggesting Perrault's syndrome. Serum gonadotropin levels were elevated. Celioscopic evaluation carried out for six patients confirmed the diagnosis. There was one case of uterine and vaginal aplasia association (Mayer-Rokytansky-Küster-Hauser syndrome). In one XY patient, SRY analysis was normal. Prophylactic gonadectomy was performed in both XY patients. Substitution therapy was initiated in 11 patients. Follow-up in 6 patients revealed development of secondary sexual characters.
  
  
  CONCLUSIONS
  The clinical, biological and histological features of our patients presenting pure gonadal dysgenesis XX were in agreement with earlier reports in the literature. Familial cases suggest possible autosomal transmission. The lack of a mutation in XY patients suggests a post-transcription anomaly. Complete or parital dysgenesis can be identified by histological analysis of the gondads.
  
  
  CONCLUSIONS
  Study of sex determining genes should provide new perspectives for earlier diagnosis and treatment of pure gondadal dysgenesis.
authors.affiliation: Service d'Endocrinologie, Diabétologie et Nutrition. CHU Ibn Sina, Rabat- Maroc.
authors.forename: A
authors.initials: A
authors.lastname: Marrakchi
authors.forename: L
authors.initials: L
authors.lastname: Belhaj
authors.forename: H
authors.initials: H
authors.lastname: Boussouf
authors.forename: A
authors.initials: A
authors.lastname: Chraibi
authors.forename: A
authors.initials: A
authors.lastname: Kadiri
mesh_terms: D000328:Adult; D000568:Amenorrhea; D015914:Estrogen Replacement Therapy; D005260:Female; D023961:Gonadal Dysgenesis, 46,XX / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D006061:Gonadal Dysgenesis, 46,XY / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D006062:Gonadotropins / Q000097:blood; D006066:Gonads / Q000601:surgery; D006801:Humans; D010535:Laparoscopy; D008297:Male; D012189:Retrospective Studies; D051876:Sex-Determining Region Y Protein / Q000032:analysis
chemical_list: D006062:Gonadotropins; C497745:SRY protein, human; D051876:Sex-Determining Region Y Protein